- Nanoemulsions play an important role in the cannabis formulation market, because they provide a reliable solution to bioavailability and insolubility problems
- The nanoemulsion market is expected to grow steadily and reach a value of $14.91 billion by 2025
- Geyser Brands has already established itself as a nanoemulsion pioneer through the development of its proprietary and highly effective NanoFusion technology
As cannabis edibles and beverages are becoming more popular, the nanoemulsions market is experiencing rapid growth. Nanoemulsion-infused cannabis beverages offer a solution to some of the most common problems that the sector is facing, including the limited efficacy of hemp-derived products caused by the insoluble nature of the molecules.
As a result, the global nanoemulsions market is expected to grow at a CAGR of 9.2 percent through 2025 to reach a value of $14.91 billion from just $6.78 billion in 2016 (http://ibn.fm/kfqLM). The legalization of cannabis products is one of the primary drivers of growth.
Insolubility problems can be addressed through the development of innovative solutions like nanoemulsion formulas. Nanoemulsions are advanced delivery systems that effectively transport therapeutic compounds into the body, enabling their effortless entry into the bloodstream for optimal effectiveness. They are stabilized fine oil/water dispersions that range in size from 20 to 600 nanometers (http://ibn.fm/RMcCQ).
Cannabis beverages based on nanoemulsion are fast acting and offer high bioavailability of active compounds. This means that the body is capable of absorbing cannabinoids in much higher amounts than typical. As a result, nanoemulsions can ensure a much better therapeutic or recreational experience.
Companies such as Geyser Brands Inc. (TSX.V: GYSR) are working to solve solubility and bioavailability problems through innovative developments. The NanoFusion technology by Geyser is made with natural materials to enhance penetration through the skin (in the case of topical product application) and improve the transportation and delivery of active ingredients across cell membranes.
Currently, NanoFusion is the only natural nanoemulsion on the market that features no solvents or inflammatory agents. In addition, it has no negative impact on the taste of beverages.
Apart from ensuring a high level of bioavailability, the NanoFusion technology also increases the shelf life of cannabis products. In addition, it makes it possible for consumers to rely on lower doses to obtain optimal therapeutic benefits from a product.
All of the products featured in Geyser’s diversified portfolio are based on NanoFusion technology. This means that the products have shown to be both reliable and capable of delivering consistent benefits to consumers.
Geyser Brands is a leading Vancouver-based consumer health care company that focuses on the development of high-quality cannabis products and brands. The company’s integrated production chain and formulation lab allow for the development of innovative products based on CBD for healthy lifestyle brands.
Geyser Brands relies on its subsidiary, Apothecary Botanicals, which operates a production facility that recently received its standard processing license from Health Canada. This license enables the company to enter the highly regulated Canadian market, with production set to begin later in 2019.
For more information, visit the company’s website at www.GeyserBrands.com
NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.